CGEMCullinan Therapeutics, Inc.

$22.84

Who owns CGEM

172 institutions reported holding CGEM for 2026Q1, together 107% of the company, more than the 151 a quarter earlier.

172

Institutions reporting a position · as of 2026Q1 · up from 151 the quarter before

Shares held by institutions
65.6M

Shares held by institutions · 107% of the company · long US equity positions only, as reported on Form 13F

Reported value
$931M

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
49%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
21
New positions
33
Positions exited
18
Added to
58
Reduced
42
Top 10 holdersof the company
68%
Institutional ownership by quarter, 2021Q1 to 2026Q1
QuarterFilersSharesReported value
2026Q117265.6M$931M
2025Q415163.2M$654M
2025Q314361.1M$362M
2025Q214262.6M$471M
2025Q114764.7M$490M
2024Q414565.6M$799M
2024Q313665.0M$1.09B
2024Q213462.9M$1.10B
2024Q111339.4M$671M
2023Q411336.9M$376M
2023Q310638.0M$344M
2023Q210636.9M$397M
2023Q110332.3M$330M
2022Q49737.7M$398M
2022Q39837.0M$475M
2022Q28937.6M$482M
Largest reported holders, 2026Q1
HolderShares% of companyValue
Lynx1 Capital Management LP9.0M15%$127M
MPM BIOIMPACT LLC7.6M12%$109M
BVF INC/IL5.8M9.4%$82M
BlackRock Inc.4.4M7.2%$63M
VANGUARD GROUP INC3.4M5.6%$49M
Kynam Capital Management, LP3.1M5.1%$44M
STATE STREET CORP2.5M4.1%$36M
PRICE T ROWE ASSOCIATES INC /MD/2.0M3.3%$29M
Blue Owl Capital Holdings LP1.9M3.1%$27M
RTW INVESTMENTS, LP1.7M2.8%$24M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…